YaoPharma’s subsidiary Carelife, recently won the 2017 Award for Top 100 Internationalized Companies for “Excellent Suppliers and Partners in International Market”.

This award is hosted by CCCMHPIE and UBM, is well recognized by the pharmaceutical companies and has a great social influence.

Carelife being given the Award is the recognition from the pharmaceutical industry for YaoPharma’s international development. In the future, YaoPharma will keep its internationalization strategy, continue to break through international barriers, realize the goal to make made-in-China medicines available to patients in US and EU and provide access to Chinese people the same quality standard medicines as developed countries and with more affordability.

Chongqing Carelife Pharmaceutical Co., Ltd. (CCPC) is an API manufacturer owned by YaoPharma. It is dedicated to the development of regulated markets and has established substantial cooperation with several famous multi-national pharmaceutical companies. More than 75% of its API products are sold to the regulated markets such as US and EU, etc. It is the largest supplier of Clindamycin Hydrochloride series of products to US market.